Trastuzumab plus Chemotherapie bei metastasierendem MagenkarzinomTrastuzumab plus chemotherapy for metastatic gastric cancer

被引：0
|
作者：
K. Schulte
机构：
[1] Kliniken der Stadt Köln gGmbH,Medizinische Klinik
[2] Krankenhaus Holweide,undefined
来源：
Der Gastroenterologe | 2010年 / 5卷 / 6期
关键词：
D O I：
10.1007/s11377-010-0484-y
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：540 / 541
页数：1
相关论文
共 50 条
  • [31] Pyrotinib plus trastuzumab versus pertuzumab plus trastuzumab in patients with HER2-positive metastatic breast cancer: A multicenter, retrospective study
    Wang, B.
    You, S.
    Xie, Y.
    Xu, F.
    Sang, D.
    Luo, T.
    Yuan, P.
    ANNALS OF ONCOLOGY, 2023, 34 : S361 - S362
  • [32] Is Pertuzumab Plus Trastuzumab Without Chemotherapy a Reasonable Treatment for ERBB2-Positive Metastatic Breast Cancer?-Reply
    Huober, Jens
    Thuerlimann, Beat
    Dietrich, Daniel
    JAMA ONCOLOGY, 2024, 10 (04) : 537 - 538
  • [33] Capecitabine plus docetaxel combination chemotherapy for metastatic breast cancer
    Saeki T.
    Takashima S.
    Breast Cancer, 2004, 11 (2) : 116 - 120
  • [34] The safety of atezolizumab plus chemotherapy for the treatment of metastatic lung cancer
    Manzo, Anna
    Carillio, Guido
    Montanino, Agnese
    Sforza, Vincenzo
    Palumbo, Giuliano
    Esposito, Giovanna
    Costanzo, Raffaele
    Sandomenico, Claudia
    La Manna, Carmine
    Martucci, Nicola
    La Rocca, Antonello
    De Luca, Giuseppe
    Piccirillo, Maria Carmela
    De Cecio, Rossella
    Botti, Gerardo
    Totaro, Giuseppe
    Muto, Paolo
    Picone, Carmine
    Normanno, Nicola
    Morabito, Alessandro
    EXPERT OPINION ON DRUG SAFETY, 2020, 19 (07) : 775 - 783
  • [35] Bevacizumab plus trastuzumab for treatment of HER2+metastatic breast cancer
    De Amuriza Chicharro, N.
    Gastalver Martin, C.
    Goyache Goni, M. P.
    Cortijo Cascajares, S.
    Garcia Munoz, C.
    Ferrari Piquero, J. M.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2013, 35 (05) : 984 - 985
  • [36] Herceptin® plus chemotherapy in relapsed and/or metastatic salivary gland cancer
    Locati, LD
    Rinaldi, G
    Bossi, P
    Licitra, L
    Dagrada, GP
    Quattrone, P
    Cantú, G
    ORAL ONCOLOGY, 2005, 41 (01) : 97 - 98
  • [37] First line chemotherapy plus trastuzumab in metastatic breast cancer HER2 positive - Observational institutional study
    Aitelhaj, Meryem
    Lkhoyaali, Siham
    Rais, Ghizlane
    Boutayeb, Saber
    Errihani, Hassan
    PAN AFRICAN MEDICAL JOURNAL, 2016, 24
  • [38] A comparative analysis of secondary data from the ToGA and EVIDENCE studies on the effectiveness of trastuzumab plus chemotherapy in Asian patients with HER2+metastatic gastric cancer
    Shen, L.
    Wu, T.
    Chen, P.
    Qin, S.
    Ji, J.
    Wu, Y.
    Chen, Y.
    Chen, Y.
    Wang, J.
    Wu, Y.
    ANNALS OF ONCOLOGY, 2021, 32 : S148 - S148
  • [39] A real-world evidence of efficacy of palliative gastrectomy plus chemotherapy in metastatic gastric cancer patients
    Yang, Lu-Ping
    Wang, Zi-Xian
    He, Ming-Ming
    Wu, Hao-Xiang
    Yuan, Shu-Qiang
    Wang, Wei
    Jin, Ying
    Ren, Chao
    Wang, Zhi-Qiang
    Wang, Feng-Hua
    Li, Yu-Hong
    Wang, Feng
    Xu, Rui-Hua
    CANCER MANAGEMENT AND RESEARCH, 2019, 11 : 3993 - 4003
  • [40] Feasibility of self-expandable metallic stent plus chemotherapy for metastatic gastric cancer with pyloric stenosis
    Shimura, Takaya
    Kataoka, Hiromi
    Sasaki, Makoto
    Yamada, Tomonori
    Hayashi, Kazuki
    Togawa, Shozo
    Okumura, Fumihiro
    Kubota, Eiji
    Ohara, Hirotaka
    Joh, Takashi
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2009, 24 (08) : 1358 - 1364
12345